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RGS (regulators of G protein signaling) proteins reg-
ulate G protein signaling by accelerating GTP hydroly-
sis, but little is known about regulation of GTPase-ac-
celerating protein (GAP) activities or roles of domains
and subunits outside the catalytic cores. RGS9-1 is the
GAP required for rapid recovery of light responses in
vertebrate photoreceptors and the only mammalian
RGS protein with a defined physiological function. It
belongs to an RGS subfamily whose members have mul-
tiple domains, including Gg-like domains that bind Gb5
proteins. Members of this subfamily play important
roles in neuronal signaling. Within the GAP complex
organized around the RGS domain of RGS9-1, we have
identified a functional role for the Gg-like-Gb5L complex
in regulation of GAP activity by an effector subunit,
cGMP phosphodiesterase g and in protein folding and
stability of RGS9-1. The C-terminal domain of RGS9-1
also plays a major role in conferring effector stimula-
tion. The sequence of the RGS domain determines
whether the sign of the effector effect will be positive or
negative. These roles were observed in vitro using full-
length proteins or fragments for RGS9-1, RGS7, Gb5S,
and Gb5L. The dependence of RGS9-1 on Gb5 co-expres-
sion for folding, stability, and function has been con-
firmed in vivo using transgenic Xenopus laevis. These
results reveal how multiple domains and regulatory
polypeptides work together to fine tune Gta
inactivation.
Most pathways for transducing signals from the cell surface
to amplified second messenger cascades within cells of animals
are organized around G proteins. Sufficient information is now
available from the genomes of nematodes and humans to con-
clude that heptahelical transmembrane proteins of the G pro-
tein-coupled class constitute by far the largest class of recep-
tors in these animals. The burden of communicating complex
signals from this enormous variety of receptors must be borne
by the relatively small number (on the order of 20) of distinct G
protein a subunits (Ga) found in these genomes. It is hard to
imagine such a scheme operating successfully unless the G
proteins are helped in their task of encoding this information
by additional regulatory proteins. Indeed, a family of proteins,
comparable in size to the Ga family, have been found to be
capable of exerting such regulation on activated Ga; these are
the RGS (regulators of G protein signaling) family of GTPase-
accelerating proteins (GAPs)1 (1, 2).
Among vertebrate RGS proteins, one whose physiological
role in G protein signaling is particularly clear is the photore-
ceptor-specific isoform RGS9-1. Removal of RGS9-1 by immu-
nodepletion (3) or gene inactivation (4) leads to loss of GTPase
acceleration for the phototransduction G protein transducin
(Gt), and without this GTPase acceleration, mouse rods have
dramatically slowed photoresponses. The catalytic core of
RGS9-1 is sufficient to accelerate GTP hydrolysis by Gt (5–7),
but there is clear evidence that RGS9-1 does not act alone in
accelerating GTP hydrolysis. The PDEg subunit of the photo-
receptor effector enzyme cGMP phosphodiesterase (PDE6) has
been known for some time to enhance GTPase acceleration (8),
and it is now established that it works by increasing the activ-
ity of RGS9-1 (3, 4). Rods of mice with a form of PDEg deficient
in RGS9-1 enhancement also have slowed photoresponse recov-
ery (9). PDEg is able to exert its GAP-enhancing effect on the
RGS9 catalytic core, but the effect is much weaker than ob-
served for endogenous RGS9-1 (6, 7, 10), implying that other
domains and/or subunits play a role in coupling GAP enhance-
ment to this effector subunit.
In addition to PDEg, the photoreceptor-specific Gb isoform
Gb5L has also been implicated in RGS9-1 function. RGS9-1 is
extracted from rod outer segments as a complex with Gb5L (11),
and RGS9-1 knockout mice are completely lacking Gb5L. The
closely related short isoform Gb5S greatly enhances the activity
of the striatal isoform RGS9–2 in an oocyte expression system
coupled to muscarinic regulation of potassium channels (12).
RGS6 and RGS7 have been isolated as complexes with Gb5S
(13, 14), and it has been proposed that members of the RGS9
subfamily of RGS proteins (RGS6, RGS7, RGS9, and RGS11 in
mammals; EGL-10 and EAT-16 in Caenorhabditis elegans,
dRGS7 in Drosophila) all bind Gb5 isoforms through their G
protein g-like (GGL) domains (15). However, the role, if any, of
Gb5S and Gb5L in regulation of GAP activity remains uncertain,
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as one report (16) described blocking by Gb5S of Ga binding to
RGS7, whereas another described GAP activity of an RGS-Gb5
complex (17), and oocyte expression experiments suggest that
Gb5S actually enhances GAP activity (12).
Regulation of activity by domains and subunits outside the
catalytic RGS domains appears to be the rule rather than the
exception for the RGS family (18–20). They contain multiple
domains with known (e.g. PDZ domains) or unknown (e.g. DEP
(dishevelled/EGL-10/pleckstrin homology) domains) functions.
RGS9-1 contains an N-terminal domain (including a DEP do-
main) of unknown function, the GGL domain, and the catalytic
RGS core domain. These are shared by the other members of
the RGS9 subfamily. In addition, RGS9-1 contains a unique
C-terminal domain, produced partly by the alternative RNA
processing, which distinguishes RGS9-1 from the striatal iso-
form RGS9–2 (21, 22). The experiments described here estab-
lish roles for different domains and for Gb5L in regulation of
GAP activity and effector coupling and in protein folding and
stability.
EXPERIMENTAL PROCEDURES
Buffers—Compositions were as follows. GAPN buffer, 10 mM Tris, pH
7.4, 100 mM NaCl, 2 mM MgCl2, 1 mM dithiothreitol; and lysis buffer, 50
mM Tris, pH 8.0, 500 mM NaCl, 1 mM dithiothreitol, 1% Nonidet P-40.
Constructs—The DNA fragments of bovine RGS9-1 encoding resi-
dues 1–484 (9NGDC), 1–219 (9N), 214–280 (9G), 214–484 (9GDC), and
291–484 (9DC), the DNA fragment of bovine RGS7 encoding residues
1–469 (7NGDC), the DNA fragment of murine RGS7 encoding residues
318–469 (7DC), and the DNA fragment of murine Gb5L encoding resi-
dues 1–395 were amplified from the corresponding cDNAs by PCR
using cloned Pfu DNA polymerase (Stratagene). The initial condons of
these fragments were replaced by NdeI restriction sites, and BamHI
restriction sites were inserted at their 39 ends. These fragments were
then cloned in frame into NdeI/BamHI sites of pET14b (Novagen) or
modified pGEX-2TK (23) vector to express N-terminal His6-tagged or
GST-tagged proteins in Escherichia coli. These fragments with N-ter-
minal His6 or GST tags were subsequently cloned into pVL1392
(PharMingen) to generate recombinant baculoviruses for expression in
Sf9 cells. The fragment from bovine RGS9 encoding residues 1–295
(9NG) was digested by NdeI/Eco47 III from the fragment of RGS9
encoding residues 1–484, cloned into pAS2 (CLONTECH) to obtain a
BamHI site to the 39 end, and then cloned into pVL1392. The mouse
Gb5L cDNA was excised using EcoRI/XbaI digestion from the plasmid,
pcDNAI-amp-Gb5L (24), and then cloned into pVL1392 to generate
recombinant baculoviruses for expression of untagged Gb5L proteins in
Sf9 cells. The fragment from bovine RGS9 encoding residues 276–431
(9D) was amplified by PCR. BamHI and EcoRI restriction sites were
inserted at its 59 end and 39 end, respectively. Then this BamHI/EcoRI
fragment was subcloned into BglII/EcoRI sites of a modified pGEX-2T
plasmid, which has a polylinker, BamHI-His6-BglII, appending to its
BamHI site. pVL1392-g9GD (residues 214–431) and pVL1392-g9NGD
(residues 1–431) were made by removing the RGS9-C domain from
pVL1392-g9GDC and pVL1392-g9NGDC. The NcoI/BamHI RGS9 frag-
ments in pVL1392-g9GDC and pVL1392-g9NGDC were replaced by the
NcoI/EcoRI RGS9 fragment of pGEX-9D. The BamHI end of the vector
and EcoRI end of the RGS9 fragment were filled with Klenow large
fragment before ligation.
The pXOP-EGFP-RGS9-1 and pXOP-Gb5L expressing plasmids were
constructed as follows. The pXOP-C1-EGFP vector (a kind gift from Dr.
Barry Knox, SUNY Upstate Medical University, Syracuse) was cut by
AgeI and ApaLI to collect the 1.7-kilobase fragment including a 1.4-
kilobase Xenopus rhodopsin promoter sequence. The promoter sequence
was then ligated to the AgeI/ApaLI pEGFP-C2 backbone to produce
pXOP-C2-EGFP. A bovine RGS9-1 cDNA EcoRI/BamHI fragment was
subcloned in frame into EcoRI/BamHI sites of pXOP-C2-EGFP to gen-
erate pXOP-EGFP-RGS9-1 expression plasmid. To construct pXOP-
Gb5L, a EcoRI/SacII Gb5L cDNA fragment was subcloned in frame into
EcoRI/SacII sites of pXOP-C2-EGFP to generate pXOP-EGFP-Gb5L.
Then the EGFP sequence was removed by digestion of AgeI/BglII. The
sticky ends were filled with Klenow large fragment and religated to
generate pXOP-Gb5L expression plasmid.
Expression and Purification of Recombinant Proteins—Recombinant
baculoviruses were isolated following cotransfection of the linearized
BaculoGold viral DNA (PharMingen) and the transfer vector into Sf9
cells according to the manufacturer’s instructions. Untagged Gb5S bal-
culovirus is a generous gift from Dr. James Garrison, University of
Virginia (25). Cells were grown as monolayers in 150-mm culture dishes
in Insect-Xpress medium (Bio Whittaker) supplemented with 8% fetal
bovine serum and 10 mg/ml gentamicin and infected with recombinant
viruses at 80% confluency and harvested 48 h later. Cell pellets were
suspended to a density of 2.5 3 107 cells/ml in lysis buffer and protease
inhibitors (0.03 mg/ml leupeptin, 0.017 mg/ml pepstatin A, 0.005 mg/ml
aprotinin, 0.03 mg/ml lima bean trypsin inhibitor, and solid phenyl-
methylsulfonyl fluoride) for 30 min at 4 °C. Cell lysates were sonicated
and then clarified by centrifugation at 20,000 3 g for 30 min at 4 °C.
The supernatants were applied to glutathione-Sepharose 4B resin (Am-
ersham Pharmacia Biotech) or nickel-nitrilotriacetic acid resin (Qiagen)
depending on the tag used. For His6-tagged proteins, 20 mM imidazole
was added to the supernatant to reduce nonspecific binding to the resin.
The resin was washed with lysis buffer and GAPN buffer plus 20 mM
imidazole, and His6-tagged protein was eluted with 250 mM imidazole
in GAPN buffer. For GST-tagged proteins, the resin was washed with
GAPN buffer, and the protein was eluted with 40 mM glutathione in
FIG. 1. Protein constructs used to
dissect roles of protein modules in
RGS9-1, RGS7, and Gb5. Major domains
are coded by position and color as indi-
cated, with linker regions in white. N-
dom. refers to the N-terminal domain (in-
cluding DEP domain) of RGS9-1. C-dom.
refers to the C-terminal domain of
RGS9-1. Tag refers to N-terminal fusions:
GST (g), His6 (h), both (gh), EGFP (f), and
none (none). Name refers to identifiers
used in text with tag label (e.g. gh) as
prefix (no prefix for no tag), e.g. g9GDC
refers to a construct with the GGL do-
main, RGS domain, and C-terminal do-
main of RGS9-1, fused to an N-terminal
GST tag. Copur. Gb5 indicates whether
the proteins were purified as a complex
with co-expressed Gb5. E/b/X refers to
expression system: E for E. coli, b for
baculovirus, and X for X. laevis. Gb5 refers
to the mixture of Gb5S and Gb5L produced
in Sf9 cells by use of alternative transla-
tion initiation sites.
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GAPN buffer. The purified proteins were stored in 220 °C in 40%
glycerol. For Gb5 expression, we routinely used a virus encoding un-
tagged Gb5L and found that both long (;60%) and short (;40%) forms
were consistently produced and co-purified with RGS9-1. Because the
short form reacts with monospecific antibodies to a common epitope in
Gb5S and Gb5L (see Fig. 2), has identical mobility to Gb5S produced by a
different virus (see Fig. 4A), and is not observed when a Gb5L expression
construct differing in its ribosome binding site and in the presence of an
N-terminal His6 fusion peptide is used (see Fig. 4A), we conclude that
the short form is likely Gb5S formed by alternative translation initiation
at the second ATG in the coding sequence.
Recombinant proteins were also expressed in E. coli using
BL21(DE3)pLysS cells and standard procedures. g9DC and h9DC were
expressed in insoluble form, so they were solubilized from inclusion
bodies using 6 M guanidinium chloride. g9DC was renatured by step
dialysis before purification. h9DC was first allowed to bind to nickel-
nitrilotriacetic acid resin under denaturing conditions and then rena-
tured on the resins according to the manufacturer’s (Qiagen) instruc-
tions. h9D was generated from the thrombin cleavage of purified gh9D
following the standard protocol and then purified by nickel-nitrilotri-
acetic acid resin.
Single Turnover GTPase Assay—Single turnover Gta GTPase assays
were carried out as described with or without exogenous PDEg (26).
Briefly, urea washed rod outer segments were mixed with purified
transducin, various amount of recombinant RGS proteins and PDEg in
GAPN buffer. Then GTP hydrolysis was initiated by adding 7 ml of
[g-32P]GTP (Amersham Pharmacia Biotech) to 14 ml of the above mix-
ture by vortexing. The reaction was quenched by 100 ml of 5% trichlo-
roacetic acid at various times, and Pi released from hydrolyzed GTP was
determined by activated charcoal assay. Final concentrations were: 15
mM rhodopsin, 1 mM transducin, and 0 or 2 mM recombinant His6-PDEg.
The first order rate constant for GTP hydrolysis (kinact) was obtained by
fitting data to single exponentials.
Antibodies and Western Blot Analysis—Polyclonal anti-RGS9-1c and
polyclonal anti-Gb5 antisera were generated as described (6, 24). Poly-
clonal anti-RGS9-N rabbit antisera were raised (Bethyl Labs) against
recombinant bovine h9N protein. Western blot analyses were per-
formed as described (6). The following dilutions of primary antibodies
were used: 1:1000 dilution of polyclonal anti-RGS9-1c antiserum, 1:500
dilution of polyclonal anti-RGS9-N antiserum, and 1:500 dilution of
polyclonal anti-Gb5 antiserum.
Transgenesis—For transgenesis, DNA was purified using the Qiagen
midi-prep protocol, and pXOP-EGFP-RGS9-1 was digested with RsrII
and pXOP-Gb5L with ApaLI. The linearized plasmids were purified
after digestion (Qiaex II, Qiagen), with final elution in water. Trans-
genic Xenopus laevis embryos were prepared by restriction enzyme-
mediated integration as described (27) except that the amounts of
restriction enzyme used (NotI) and egg extract were reduced to 0.15
units and 2 ml/transgenesis reaction, respectively. Restriction enzyme-
mediated integration was carried out in 0.43 MMR (28) containing 6%
(w/v) Ficoll. 13 MMR contains 100 mM NaCl, 2 mM KCl, 1 mM MgCl2,
2 mM CaCl2, 5 mM HEPES, pH 7.4. Embryos were transferred to 0.13
MMR, 6% Ficoll at the 4–8 cell stage. Properly gastrulating embryos
were raised in 0.13 MMR until approximately stage 42 (29) and then
transferred to dechlorinated water. Tadpoles were anesthetized in
0.01% 3-aminobenzoic acid ethyl ester (Sigma) and monitored for green
fluorescent protein expression using an Olympus fluorescent dissecting
microscope. To extract genomic DNA, tadpoles were sacrificed and
incubated over night at 55 °C in 50 mM Tris, pH 8.0, 50 mM EDTA, 0.5%
SDS and 100 mg/ml proteinase K (Life Technologies, Inc.). After phenol-
FIG. 2. RGS9-1 and Gb5 solubility depends on heterodimer formation. GST-tagged proteins were expressed in Sf9 cells and then extracted
with detergent (wherever present, detergent was 1% Nonidet P-40). Samples of the cell pellets and supernatants (Cell sup.) after detergent
extraction were used for immunoblot analysis, and the remaining supernatants were loaded onto glutathione beads. After washing, proteins were
eluted in GSH buffer with or without detergent as indicated in A and B and with detergent in C and D. In all panels, RGS9-1 and Gb5 were detected
on immunoblots by anti-RGS9-1c antiserum and anti-Gb5 antiserum except that g9N in C was detected by anti-RGS9-N antiserum. A, GST-tagged
RGS9-1 (g9NGDC) was effectively eluted in soluble form without detergent only when co-expressed with Gb5 and purified as a complex. g9NGDC
was expressed in Sf9 cells with or without co-expression of Gb5 and then purified by GSH affinity column. B, His6-tagged Gb5L (hGb5L) was
effectively eluted in soluble form as a complex with GST-tagged RGS9-1 (g9NGDC) without detergent. hGb5L was expressed in Sf9 cells with or
without co-expression of g9NGDC and then purified by immobilized Ni21 affinity chromatography. C, the GGL domain of RGS9-1 was necessary
and sufficient for the binding of Gb5. GST-tagged RGS9-1 fragments were co-expressed with Gb5 in Sf9 cells, and affinity purified using detergent
in the GSH elution buffer. D, efficient formation and stability of the g9NGDCzGb5 complex in Sf9 cells required co-expression. g9NGDC was affinity
purified either from the mixed extracts of cells separately infected by g9NGDC and Gb5 baculoviruses (Mix.) or from the extracts of cells
simultaneously infected by g9NGDC and Gb5 baculoviruses (Co-exp.).
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chloroform extraction, DNA was precipitated by adding 2 volumes of
100% ethanol. The DNA pellets were washed in 1 ml of 70% ethanol,
dried by speed vacuum, and resuspended in TE. About 0.4 mg of
genomic DNA was used as template in PCR reactions.
RESULTS
Dependence on Heterodimer Formation of RGS9-1 and Gb5
Solubility—To dissect the roles of individual protein modules
in the RGS9-1zGb5 complex, we expressed and purified a num-
ber of protein fragments and complexes (Fig. 1). Full-length
RGS9-1 is readily expressed at high levels in either bacterial
(6) or baculovirus (Fig. 2) systems but is produced almost
entirely in an insoluble form (data not shown). In the detergent
Nonidet P-40, RGS9-1 and Gb5 can be extracted from insect
cells into solution for affinity purification. We observed a strik-
ing difference between the behavior of RGS9-1 with and with-
out Gb5: RGS9-1 is eluted from the affinity matrix in soluble
form without detergent when bound to Gb5, (Figs. 2, A and B,
and 4A) but in the absence of Gb5 can only be eluted when
detergent is added. Moreover, once purified, RGS9-1 without
Gb5 precipitates when Nonidet P-40 is removed, whether by
dilution or slow dialysis. It precipitates even when Nonidet
P-40 is exchanged for either of two detergents shown previously
to solubilize the RGS9-1zGb5L complex from photoreceptor
membranes in active form, octyl glucoside (3) or lauryl sucrose
(11) (data not shown). Gb5L also displayed a dependence on
RGS9-1 for solubility, but it was less stringent. Some hGb5L
could be recovered in soluble form without RGS9-1, but the
amount was significantly reduced (Fig. 2B).
RGS9-1 Binds Gb5 through the Gg-like Domain—The forma-
tion of the RGS9-1zGb5 complex is clearly mediated through the
GGL domain of RGS9-1. All GST-tagged fragments containing
the GGL domain co-purified with co-expressed Gb5 (Fig. 2C),
including a GST-GGL construct (g9G), whereas constructs con-
taining either the RGS9-1 domains N-terminal to the GGL
domain (g9N) or those C-terminal to the GGL domain (g9DC)
or both (g9NDC) did not bind co-expressed Gb5. RGS7, which
also contains a GGL domain, also co-purified with Gb5 (see Fig.
4A).
Efficient formation and stability of the RGS9-1zGb5 complex
required co-expression (Fig. 2D). When cells were simulta-
neously infected with viruses expressing RGS9-1 and Gb5, the
complex was readily co-purified. In contrast, when extracts of
cells separately infected with the two different virus prepara-
tions were mixed, very little of the complex formed as revealed
by the much lower amount of Gb5 co-purifying with RGS9-1.
Thus, Gb5 is required during or immediately after translation
for efficient formation of the RGS9-1zGb5 complex.
Co-expression of Gb5 Is Required for RGS9-1 Expression in
Vivo—Further evidence for a dependence on Gb5 for production
of functional RGS9-1 was provided in vivo by transgenesis
experiments in X. laevis. In five trials in which a construct
directing expression of a EGFP-RGS9-1 fusion (f9NGDC; Fig.
3A) was used for fertilization without a Gb5L construct, none of
the surviving tadpoles displayed detectable EGFP signal in
their eyes. Genotyping of 19 revealed that 11 had the transgene
inserted in their genomes. In four trials in which f9NGDC and
Gb5L constructs were co-injected, at least one tadpole with
detectable retinal EGFP signal (Fig. 3C) was obtained every
time. Genotyping of five animals with integrated f9NGDC con-
struct and detectable retinal EGFP signal revealed that the
Gb5L construct was also integrated in all (Fig. 3B). No animals
expressing detectable levels of EGFP-RGS9-1 have been found
to date that do not have the Gb5L construct integrated, al-
though two tadpoles containing integrated EGFP-RGS9-1 but
not Gb5L were found among the tadpoles without detectable
signal from one co-injection trial. In all these trials we have not
found a single animal that has both f9NGDC and Gb5L con-
structs integrated but that displays no retinal EGFP signal.
FIG. 3. Expression of EGFP-RGS9-1 in transgenic Xenopus tadpoles requires Gb5L. A, maps of transgene constructs pXOP-EGFP-RGS9-1
and pXOP-Gb5L. On the map lines, the 1.4-kilobase rhodopsin promoter sequences are shown as hatched boxes, EGFP coding sequences is shown
as a solid green box, coding sequences for RGS9-1 are shown as open boxes, and coding sequences for Gb5L are shown as a light blue box. Arrows
represent the primers for PCR genotyping. B, genomic DNA purified from 1 month old tadpole with EGFP retinal-expression phenotype (T2),
tadpole without EGFP phenotype (T1), and control wild type tadpole (W) were analyzed by PCR to detect the integration of XOP-EGFP-RGS9-1
(left panel) and XOP-Gb5L (right panel). For each analysis, transgene constructs (P) were used as positive control. The predicted size for PCR
products of RGS9-1 and Gb5L transgenes are 500 and 383 base pairs, respectively. C, green fluorescent protein fluorescence in an eye of a wild type
tadpole (panel a), a transgenic tadpole with XOP-EGFP-RGS9-1 (panel b), and a transgenic tadpole with both XOP-EGFP-RGS9-1 and XOP-Gb5L
(panel c). The bright green fluorescent protein fluorescence was only observed from the tadpole bearing both EGFP-RGS9-1 and Gb5L. Panel d,
lateral view of another transgenic tadpole with both EGFP-RGS9-1 and Gb5L transgenes. The picture is a combination of a bright field image and
a fluorescence field image.
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Thus, just as Gb5L protein expression in murine photoreceptor
cells requires the presence of RGS9-1 (4), RGS9-1 expression
(or at least, detectable overexpression of our construct) in Xe-
nopus photoreceptors requires the presence of Gb5L.
GAP Activity and Effector Regulation of RGS9-1zGb5
Complex—Once sufficient amounts of the RGS9-1zGb5 complex
had been purified from infected SF9 cells (Fig. 4A), we were
able to check it for catalytic activity. It has been previously
suggested (30) that the rod outer segment GAP, or the RGS9-
1zGb5L complex, has no GAP activity in the absence of PDEg. As
shown in Fig. 4B, just as rod outer segment membranes ex-
haustively washed to remove PDE show significant GAP activ-
ity toward Gta (31), recombinant RGS9-1zGb5 significantly ac-
celerates GTP hydrolysis by Gta in the absence of any subunits
of PDE. Thus, the GAP activity of this complex does not have
an absolute requirement for PDEg. However, PDEg does en-
hance its GAP activity greatly. As shown in Fig. 4C, the en-
hancement is very similar to that observed for the endogenous
GAP in rod outer segment membranes, in marked contrast to
previous observations for the core RGS domain (5–7, 10). As
with other RGS proteins, the core RGS domain of RGS9-1 is
sufficient to accelerate GTP hydrolysis by Gta. However, en-
hancement of the GAP activity of the RGS domain of RGS9 by
PDEg is very modest. Thus, the additional protein modules in
the RGS9-1zGb5 complex must contribute most of the interac-
tions required for regulation by PDEg.
All Domains of RGS9-1 Contribute to Regulation of GAP
Activity and Effector Coupling—The constructs described in
Fig. 1 allowed us to assess the relative contributions of differ-
ent protein modules in the RGS9-1zGb5 complex to GAP activity
with and without PDEg (Fig. 5). Interestingly, when assayed at
6 mM, in the presence of PDEg, the GAP activities of all con-
structs in Fig. 5 (A–D) were similar, with none differing from
any other by more than a factor of two. The most striking
differences were observed in the absence of PDEg. GAP prep-
arations containing the GGL domainzGb5 complex (Fig. 5, A and
D) had lower basal GAP activity than those containing only the
RGS core domain or the RGS domain plus the C-terminal
domain (Fig. 5, B and C), especially at concentrations above 1
mM. Comparison of the results from different proteins assayed
in Fig. 5 suggests that the GGL domainzGb5 complex confers
most of the effector sensitivity and does so primarily by inhi-
bition of GAP activity in the absence of PDEg. Because the
complex containing only the short form of Gb5 (g9NGDCzGb5S;
Fig. 5A) had identical activity to that of the complex containing
a mixture of Gb5 isoforms (g9NGDCzGb5) with about 60% Gb5L,
the additional 42 amino acid residues on the long isoform do
not play an important role in regulating GAP activity or PDEg
enhancement.
The N-terminal domain, containing the DEP module, also
seems to play a role through a modest enhancement of PDEg-
stimulated GAP activity as revealed by comparison of Fig. 5 (A
FIG. 4. The GAP activity of the
complex of GST-tagged RGS9-1
(g9NGDC) and Gb5. A, purification
of g9NGDCzGb5, g9NGDCzGb5S,
g9NGDCzhGzb5L, g7NGDCz Gb5S, and
g7NGDCzhGb5L complexes. g9NGDC and
Gb5, g9NGDC and Gb5S, g9NGDC and
hGb5L, g7NGDC and Gb5S, or g7NGDC
and hGb5L were coexpressed in Sf9 cells
and then purified by GSH affinity col-
umn. No detergent was present in the
elution buffer. Pellets of cell lysates (lanes
a), supernatants of cell lysates (lanes b;
10% relative to lanes a), and the purified
complexes (lanes c; g9NGDCzGb5, 0.6 mg;
g9NGDCzGb5S, 1.0 mg; g9NGDCzhGb5L,
1.0 mg; g7NGDCzGb5S, 1.5 mg;
g7NGDCzhGb5L, 1.0 mg) were separated
on SDS-PAGE and stained by Coomassie
Blue. B, concentration dependence of the
GAP activity of g9NGDCzGb5 without
PDEg. C, PDEg enhancement of GAP ac-
tivity of endogenous RGS9-1zGb5L
(9NGDCzGb5L) complex and g9NGDCzGb5
complex (1 mM). Endogenous RGS9-1zGb5L
was supplied as isotonically washed rod
outer segment membranes at a final R*
concentration of 15 mM. Single turn-
over GTPase assays of Gta were carried
out as described under “Experimental
Procedures.”
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and D). We also compared h9NGDCzGb5 to g9NGDCzGb5 and
found little difference (,11%) in basal or PDEg-stimulated
GAP activities for the different N-terminal fusions (data not
shown), consistent with a noncritical role for the N-terminal
domain of RGS9.
The C-terminal domain of RGS9-1 also plays an important
role but only in the context of a complex containing the co-
valently attached GGL-Gb5 couple. Complexes of Gb5 with both
g9NGD (Fig. 5E) and g9GD (Fig. 5F) showed low basal GAP
activity, as observed for the corresponding complexes contain-
ing the C-terminal domain (g9NGDC, Fig. 5A; g9GDC, Fig.
5D), indicating that covalently attached GGL-Gb5 is sufficient
to inhibit the GAP activity of the RGS core domain. However,
PDEg only weakly countered the inhibition of GAP activity
conferred by GGL-Gb5 in the absence of the C-terminal domain,
strongly suggesting that the C-terminal domain is required to
work cooperatively with PDEg to relieve inhibition by GGL-
Gb5. In the absence of GGL-Gb5, the effect of removing the
C-terminal domain is less dramatic. The g9DC construct dis-
plays an anomalous cooperative behavior (Fig. 5C) not seen
with the other constructs (although there is a hint of such
behavior for gh9D; Fig. 5B). This apparent cooperativity is not
due to the well known GST dimerization equilibrium as it is
also clearly seen in the His6-tagged construct h9DC (Fig. 5C,
inset). Given this behavior, it is hard to attribute much signif-
icance to the small differences in PDEg enhancement seen in
comparing Figs. 5 (B and C). Thus, the C-terminal domain
must interact directly or indirectly with the GGL-Gb5 module
to explain the differences between the results shown in Fig. 5
(E and F) as compared with those in 5B and 5C. In separate
studies,2 we have found that the C-terminal domain of RGS9-1
is important for tethering RGS9-1 to membranes, possibly pro-
viding an additional indirect role for this domain in effector
coupling by localizing the RGS9-1zGb5L complex on the disc
membranes where PDE resides.
GGL Domain Containing Gb5 Complexes Acts as Functional
Modules without Attached RGS Domain—We also explored
whether the Gb5zGGL domain complex could influence activity
of the RGS domain when they were not covalently attached.
The two complexes tested, gGb5Lz9G and g9NGzGb5, had no
influence on GTP hydrolysis of Gta without the RGS domain in
the absence or presence of PDEg, nor did they affect GAP
activity of a complex (h9GDCzGb5) containing the GGL domain
covalently attached to the RGS domain (Fig. 6). However, they
strongly influenced the GAP activity of the RGS domain in
either h9D or h9DC (Fig. 6). They mimicked the covalently
attached GGL domain complexed to Gb5 in enhancing the GAP
stimulation by PDEg but surprisingly stimulated, rather than
inhibited, GAP activity in the absence of PDEg. These results
suggest a model (Fig. 6C) in which PDEg induces a change from
an inhibitory conformation imposed by the covalent attach-
ment of the NGzGb5 modules to a catalysis-promoting confor-
mation that is also available when NGzGb5 is not constrained
by covalent attachment but is still stabilized by PDEg in that
case.
The RGS Domain Determines whether PDEg Enhances or
Inhibits GAP Activity—Finally, to assess the specificity of these
interactions, we compared RGS9-1 and the closely related neu-
ronal RGS protein, RGS7 (Fig. 7). Like g9NGDCzGb5,
g7NGDCzGb5 displays GAP activity in the absence of PDEg, but
in sharp contrast to RGS9-1, this RGS7 complex is not stimu-
lated but rather inhibited by PDEg (Fig. 7A). The PDEg inhi-
bition was still observed even when Gb5S was replaced by hGb5L
(Fig. 4A) for formation of the complex with RGS7 (data not
shown), indicating that the PDEg inhibition is intrinsic to
RGS7 and not a result of its binding to Gb5S rather than to
Gb5L.
The effects of g9NGzGb5 on the RGS domain of RGS7 (h7DC)
are similar to its effects on RGS9-1 (h9DC); basal GAP activity
is enhanced, and modulation of activity by PDEg is enhanced.
The striking difference is that as observed for all RGS proteins
tested so far besides RGS9-1, the effect of PDEg is inhibition,
rather than stimulation, of GAP activity (Fig. 7B). Taken to-
gether with previous studies (5, 10), these results support the
conclusion that although GGLzGb5 and perhaps the N-terminal
domain are important in determining the basal activity and the
extent of PDEg modulation, the sign of the modulation (nega-
tive or positive) is determined by key residues within the RGS
domain.
DISCUSSION
Three major conclusions emerge from the work described
here: 1) RGS9-1 and Gb5L act as an obligate heterodimer. The
function and even the production and maintenance of each
depends upon the other. This mutual dependence is observed at
the levels of GAP activity, solubility, and conformational sta-
bility of the recombinant proteins in vitro and at the level of
protein expression in vivo. 2) Gb5L confers tight regulation by
the effector subunit PDEg on the catalytic RGS domain. It
2 W. He and T. G. Wensel, unpublished observations.
FIG. 5. Contribution of protein modules to the basal GAP ac-
tivity and effector regulation. Single turnover assays of Gta GTPase
with (filled symbols) or without (open symbols) PDEg. Concentration
dependence of the GAP activity was as follows: A, g9NGDCzGb5 (circles)
and g9NGDCzGb5S (triangles); B, gh9D (inset, h9D); C, g9DC (inset,
h9DC); D, g9GDCzGb5; E, g9NGDzGb5; F, g9GDzGb5.
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seems likely that the complexity of this GAP, far greater than
that needed for simple constitutive acceleration of Gta GTP
hydrolysis, has evolved to provide fine tuning of the kinetics of
inactivation. 3) The domains of RGS9-1 external to the cata-
lytic RGS domain contribute to the tight regulation and fine
tuning by Gb5L and PDEg. The GGL domain is required for
recruiting Gb5L, and these two modules provide most of the
regulatory interactions. The C-terminal domain, unique to
RGS9-1, is essential for enabling PDEg to overcome the inhi-
bition imposed by GGL-Gb5, and the N-terminal domain may
play a minor role as well.
The conclusion from the present work that RGS9-1 and Gb5L
require one another for proper structure and function complies
well with previous observations. When elution of detergent-
solubilized RGS9-1 from various chromatography columns was
monitored by specific antibodies, Gb5L was found to co-elute
(11). RGS9-1 knockout mice (4) contained no detectable Gb5L
protein, despite the presence of mRNA at normal levels or
higher. Likewise, co-precipitation of Gb5S with RGS7 antibod-
ies (13, 32) and of RGS7 and RGS6 with Gb5 antibodies (14)
points to obligate heterodimeric (or higher order) complexes for
these proteins as well. RGS7 has also been found to require
FIG. 6. The N-terminal RGS9 do-
main and GGLzGb5 complex both con-
tribute to effector dependence, even
without covalent linkage to catalytic
domain. Single turnover assays of Gta
GTPase with and without PDEg. A, addi-
tion of g9NGzGb5 significantly enhances
the GAP activity of h9D, whereas it has
no effect on h9GDCzGb5. g9NGzGb5 itself
has no detectable GAP activity. B, addi-
tion of gGb5Lz9G significantly enhances
the GAP activity of h9DC. gGb5Lz9G itself
has no detectable GAP activity. C, sche-
matic model for the modulation of the
GAP activity of the RGS core domain by
modules within the RGS9-1zGb5L com-
plex. The expected secondary structure of
the RGS domain is suggested by use of the
RGS4 structure (37), and those of Gta, the
GGL domain, and Gb5L by use of the Gta-
GDP, Gtg, and Gtb structures, respec-
tively, from the transducin heterotrimer
structure (38). Positions and shapes of
modules are intended as purely schematic
representations.
FIG. 7. Direction of PDEg effect (enhancement or inhibition) on the GAP activity of RGS members is determined by the RGS
domains. Single turnover assays of Gta GTPase with or without PDEg. A, concentration dependence of the GAP activity of g7NGDCzGb5S and
g9NGDCzGb5. In contrast to g9NGDCzGb5, the GAP activity of g7NGDCzGb5S is not stimulated but rather inhibited by PDEg. B, addition of
g9NGzGb5 significantly enhances the GAP activity of both h9DC and h7DC but does not change the direction of PDEg effect on the GAP activity
of h9DC (enhancement) and the GAP activity of h7DC (inhibition).
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co-expression of Gb5 to allow isolation in stable soluble form
from baculovirus-infected insect cells (33) or transfected COS-7
cells (32).
Our results also form a coherent picture when compared
with the folding and stability requirements of conventional Gb
subunits. Gb translated in vitro in the absence of Gg has a less
compact structure than Gbg, is unstable, and tends to aggre-
gate (34). Gb2 and Gg2 subunits, when expressed independently
in insect cells, could be purified using detergent but did not
form an active complex when mixed (35).
Although we cannot say with certainty whether the mutual
dependence of RGS9-1 and Gb5L in vivo is at the level of
translation, folding, stabilization against aggregation, and pro-
teolysis or all three, the in vitro results imply that both folding
and stabilization of each subunit depends on the other.
Reports on the roles of Gb5S and Gb5L in regulation of GAP
activity are somewhat less consistent. In one case, Gb5S was
described as blocking binding of RGS7 to Ga, suggesting that it
could block GAP activity (16). However, RGS11 bound to Gb5
displayed GAP activity toward Goa (17), and Gb5S co-expression
dramatically enhanced the activities of both RGS7 and
RGS9–2 in accelerating muscarinic responses of GIRK chan-
nels in an oocyte expression system (12). Our results indicate
that Gb5S and Gb5L can either enhance or inhibit GAP activity,
depending on additional interactions, such as those with the
effector. Thus, the function of Gb5S and Gb5L appears to be to
provide additional constraints on catalytic activity that allow
for fine tuning of response kinetics. Gb5L and Gb5S are also
likely involved in discrimination by RGS proteins among Ga
subunits. The RGS domain of RGS7 efficiently accelerates GTP
hydrolysis by either Gia1 or Goa (36), but the RGS7zGb5S com-
plex only works well with Goa (33).
The results described here do not reveal whether Gb5L inter-
acts directly with Gta, but if it does the mode of binding during
GTPase acceleration must very different from that of Gb1 bind-
ing to Gta-GDP, because several key residues of Ga involved in
Gb1 interactions are occluded by the RGS domain in the Gia-
RGS4 structure (37). In this structure, the C and N termini of
the RGS domain were in relatively close proximity, so it may be
that the C terminus of RGS9-1 is positioned near or in contact
with Gb5LzGGL.
The dramatic effects of PDEg on GAP activity of the RGS9-
1zGb5L complex, as compared with its very modest effects on the
RGS domain (6), suggest a conformational switch involving
Gb5L, the GGL domain, the RGS domain, the C-terminal do-
main, and PDEg. Because the dependence on PDEg is greatly
reduced when the Gb5LzGGL complex is not covalently attached
to the RGS domain, it seems likely that the connecting peptide
chain (25 residues between the positions corresponding to the
end of the C-terminal a helix of Gg and the beginning of the
N-terminal helix of the RGS domain), imposes an inhibitory
constraint that is relieved by PDEg (Fig. 6C). Thus PDEg likely
affects not the conformational state of the Gb5LzGGL itself so
much as its position relative to the RGS domain. Because many
features of this machinery are conserved in the complexes of
Gb5S with RGS7, RGS6, RGS11, and likely EGL-10, similar
conformational switching mechanisms, involving effectors or
other regulatory proteins, may regulate their activities as well.
Such mechanisms may help to explain how RGS proteins, ini-
tially thought to be rather promiscuous in their actions, can
select not only the G protein-effector pairs on which they
should act but also the times at which they should do so.
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